Poland· PL-100337788
Epoetin alfa Hexal
A erythropoietin product containing epoetinum alfa, registered in Poland by Hexal AG. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Erythropoietin is registered in 12 of 19 countries.
Countries holding a registration under ATC B03XA01 (erythropoietin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Erythropoietin · ATC B03XA01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Epoetinum alfa
- Manufacturer
- Hexal AG
- Country
- Poland (PL)
- ATC code
- B03XA01
- ATC class
- Erythropoietin
- Defined daily dose
- 1 TSD, E
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990737741
- gtin05909990737758
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
18 interactions on record for erythropoietin.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Erythropoietin · interactions on record
18 records
- 5 severe
- 3 moderate
- 10 minor
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- ThalidomideL04AX02severe
- LenalidomideL04AX04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Erythropoietin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaABSEAMEDMedice Arzneimittel Pütter GmbH & Co. KG, Iserlohn
- FinlandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG
- BelgiumAbseamed 1000 IU/0.5 mlMedice Arzneimittel Pütter
- IcelandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG*
- NetherlandsAbseamed 10.000 IE/1 ml oplossing voor injectie in een voorgevulde spuitMedice Arzneimittel Pütter GmbH & Co. KG
- SwedenAbseamed 10 000 IE/ 1 ml Injektionsvätska, lösning i förfylld sprutaMedice Arzneimittel Pütter GmbH & Co. KG
- IrelandAbseamed 1 000 IU/0.5 mL solution for injection in a pre-filled syringeMedice Arzneimittel Putter GmbH & Co. K.G
- United KingdomBinocrit 1,000units/0.5ml solution for injection pre-filled syringesSandoz Ltd
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Erypo
- Belgium · Eprex
- Czechia · Eprex
- Germany · Erypo Fs
- Spain · Eprex
- France · Eprex
- United Kingdom (Northern Ireland) · Eprex
- Greece · Eprex
- Iceland · Abseamed, Binocrit
- Italy · Eprex
- Liechtenstein · Binocrit, Epoetin Alfa Hexal
- Luxembourg · Eprex
- Netherlands · Eprex
- Norway · Abseamed, Binocrit
- Portugal · Eprex
- Slovenia · Eprex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b24138ce-d008-4b63-a533-ede203807266 GET /v1/drugs/b24138ce-d008-4b63-a533-ede203807266?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "20 000 j.m./0,5 ml",
"packaging": "05909990737741 ¦ Rpz ¦ EU/1/07/411/021 ¦ 106996\n1 amp.-strzyk. 0,5 ml\nRpz ¦ EU/1/07/411/053 ¦ 106997\n4 amp.-strzyk. 0,5 ml\n05909990737758 ¦ Rpz ¦ EU/1/07/411/022 ¦ 106998\n6 amp.-strzyk. 0,5 ml\nRpz ¦ EU/1/07/411/047 ¦ 131642\n1 amp.-strzyk. 0,5 ml\nRpz ¦ EU/1/07/411/048 ¦ 131643\n6 amp.-strzyk. 0,5 ml",
"substance": "Epoetinum alfa 20000 j.m./0,5 ml",
"common_name": "Epoetinum alfa",
"pl_product_id": "100337788",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about erythropoietin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.